Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF NORHARMAN IN PREPARATION OF MEDICINE FOR PREVENTING OR TREATING ACUTE PANCREATITIS
Document Type and Number:
WIPO Patent Application WO/2023/123834
Kind Code:
A1
Abstract:
The present invention relates to the field of medicines. Disclosed is a use of Norharman in preparation of a medicine for preventing or treating acute pancreatitis. Norharman reduces the levels of serum amylase and lipase, and ameliorates pancreatic and intestinal tissue damage. Norharman ameliorates acute pancreatitis by modulating macrophage M1 type polarization. The results of the present invention show that Norharman has deep research and development values in the aspect of acute pancreatitis. The results of the present invention provide a new direction and idea for enhancing the amelioration effect of Norharman on acute pancreatitis, and provide experimental data and a new research and development direction for research and development of innovative medicines in the aspect of acute pancreatitis.

Inventors:
XIANG HONG (CN)
SHANG DONG (CN)
TAO XUFENG (CN)
ZHOU QI (CN)
GUO FANGYUE (CN)
WU YU (CN)
Application Number:
PCT/CN2022/094667
Publication Date:
July 06, 2023
Filing Date:
May 24, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
THE FIRST AFFILIATED HOSPITAL OF DALIAN MEDICAL UNIV (CN)
International Classes:
A61P1/18; A61K31/437
Domestic Patent References:
WO2007054348A12007-05-18
Foreign References:
CN114288291A2022-04-08
KR101646916B12016-08-09
CN112135613A2020-12-25
Other References:
YUFENG FU, HU SHAODONG,DUAN KUN,WANG BAOLIN,SUN ZHITAO, LU CHANGTONG,TIAN HAIYING,HAO HUI: "Research Progress of the Major HAAs", JOURNAL OF LIGHT INDUSTRY, vol. 33, no. 1, 31 January 2018 (2018-01-31), pages 13 - 25, XP093074574
Attorney, Agent or Firm:
DALIAN EAST PATENT AGENT LTD. (CN)
Download PDF: